207 WEST 25TH ST, 9TH FLOOR, NEW YORK, NY
October 2025 INVESTOR PRESENTATION 'Pioneering Real Time Biochemistry That Drives AI - Led, Personalized Healthcare Technologies'
Profusa, Inc. Increases Authorized Shares to 600 Million
October 2025 INVESTOR PRESENTATION 'Pioneering real time biochemistry that drives AI - led, personalized healthcare technologies'
Invests Additional $1 Million in Digital Treasury Assets
News
News, Material Contracts
Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO
Q2
Q1
Notice of Late Filing for Quarterly Report
FY 2024
Q3
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Effectiveness Notice
Amended Registration Statement for Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Definitive Information Statement
Preliminary Information Statement
Initial Statement of Beneficial Ownership
Notification Filed by a National Security Exchange
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Submission Upload
Correspondence
S-1MEF